Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADUS Addus HomeCare	$112.07 +1.3%	$111.79	$88.96 ▼ $136.72	$2.06B	0.81	166,123 shs	160,557 shs
HQY HealthEquity	$103.12 +1.3%	$100.09	$65.01 ▼ $116.65	$8.92B	0.49	863,458 shs	972,980 shs
MEDP Medpace	$322.50 +1.1%	$304.15	$250.05 ▼ $459.77	$9.27B	1.47	374,774 shs	342,581 shs
MMSI Merit Medical Systems	$95.34 +4.6%	$94.66	$82.62 ▼ $111.45	$5.63B	0.65	539,372 shs	1.01 million shs

A Beginner's Guide to Investing in Cannabis

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADUS Addus HomeCare	-1.11%	-3.97%	-2.22%	+14.85%	-6.04%
HQY HealthEquity	+2.29%	-2.80%	-8.71%	+32.64%	+23.33%
MEDP Medpace	-0.81%	+1.61%	+7.55%	+15.03%	-20.75%
MMSI Merit Medical Systems	-2.60%	-2.52%	-4.37%	+2.98%	+6.54%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ADUS Addus HomeCare	4.99 of 5 stars	3.6	5.0	5.0	3.9	2.5	3.1
HQY HealthEquity	3.6016 of 5 stars	3.5	3.0	0.0	2.2	2.5	1.9
MEDP Medpace	4.4512 of 5 stars	2.1	2.0	4.6	2.2	4.2	2.5
MMSI Merit Medical Systems	4.3944 of 5 stars	3.4	2.0	3.8	2.7	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADUS Addus HomeCare	3.25	Buy	$142.57	27.22% Upside
HQY HealthEquity	3.00	Buy	$118.55	14.96% Upside
MEDP Medpace	2.21	Hold	$344.82	6.92% Upside
MMSI Merit Medical Systems	2.89	Moderate Buy	$109.11	14.44% Upside

Current Analyst Ratings Breakdown

Latest MMSI, ADUS, HQY, and MEDP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/8/2025	HQY HealthEquity	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Strong-Buy ➝ Strong-Buy	$115.00 ➝ $120.00
7/8/2025	MMSI Merit Medical Systems	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$108.00
6/24/2025	MEDP Medpace	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform ➝ Equal Weight	$300.00
6/20/2025	ADUS Addus HomeCare	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$150.00
6/10/2025	ADUS Addus HomeCare	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$133.00
6/5/2025	HQY HealthEquity	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$112.00 ➝ $125.00
6/5/2025	HQY HealthEquity	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$98.00 ➝ $115.00
6/4/2025	HQY HealthEquity	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$94.00 ➝ $104.00
6/4/2025	HQY HealthEquity	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$112.00 ➝ $117.00
6/4/2025	HQY HealthEquity	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Outperform ➝ Market Outperform	$110.00 ➝ $117.00
6/4/2025	HQY HealthEquity	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$110.00 ➝ $125.00

(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADUS Addus HomeCare	$1.15B	1.79	$5.40 per share	20.75	$53.52 per share	2.09
HQY HealthEquity	$1.20B	7.43	$4.30 per share	23.96	$24.40 per share	4.23
MEDP Medpace	$2.11B	4.39	$14.00 per share	23.04	$26.56 per share	12.14
MMSI Merit Medical Systems	$1.36B	4.15	$5.71 per share	16.69	$23.67 per share	4.03

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADUS Addus HomeCare	$73.60M	$4.43	25.30	20.91	1.58	6.52%	9.23%	6.96%	8/4/2025 (Estimated)
HQY HealthEquity	$96.70M	$1.37	75.27	36.31	1.57	9.80%	11.01%	6.77%	9/2/2025 (Estimated)
MEDP Medpace	$404.39M	$13.10	24.62	23.61	5.80	19.31%	54.36%	20.81%	7/21/2025 (Confirmed)
MMSI Merit Medical Systems	$120.36M	$2.04	46.74	25.42	3.08	8.81%	15.52%	8.72%	7/30/2025 (Estimated)

Latest MMSI, ADUS, HQY, and MEDP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/4/2025	Q2 2025	ADUS Addus HomeCare	$1.45	N/A	N/A	N/A	$345.71 million	N/A
7/30/2025	Q2 2025	MMSI Merit Medical Systems	$0.8480	N/A	N/A	N/A	$372.47 million	N/A
7/21/2025	Q2 2025	MEDP Medpace	$3.01	N/A	N/A	N/A	$537.70 million	N/A
6/3/2025	Q1 2026	HQY HealthEquity	$0.81	$0.97	+$0.16	$0.61	$322.25 million	$330.80 million
5/5/2025	Q1 2025	ADUS Addus HomeCare	$1.33	$1.42	+$0.09	$1.16	$341.66 million	$337.71 million
4/24/2025	Q1 2025	MMSI Merit Medical Systems	$0.75	$0.86	+$0.11	$0.49	$352.57 million	$355.35 million
4/21/2025	Q1 2025	MEDP Medpace	$3.06	$3.67	+$0.61	$3.67	$528.38 million	$558.57 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADUS Addus HomeCare	N/A	N/A	N/A	N/A	N/A
HQY HealthEquity	N/A	N/A	N/A	N/A	N/A
MEDP Medpace	N/A	N/A	N/A	N/A	N/A
MMSI Merit Medical Systems	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADUS Addus HomeCare	0.20	1.74	1.74
HQY HealthEquity	0.50	4.06	4.06
MEDP Medpace	N/A	0.73	0.73
MMSI Merit Medical Systems	0.51	4.87	3.26

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADUS Addus HomeCare	95.35%
HQY HealthEquity	99.55%
MEDP Medpace	77.98%
MMSI Merit Medical Systems	99.66%

Insider Ownership

Company	Insider Ownership
ADUS Addus HomeCare	4.60%
HQY HealthEquity	1.50%
MEDP Medpace	20.30%
MMSI Merit Medical Systems	3.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADUS Addus HomeCare	49,703	18.40 million	17.55 million	Optionable
HQY HealthEquity	3,120	86.47 million	85.18 million	Optionable
MEDP Medpace	5,900	28.74 million	22.91 million	Optionable
MMSI Merit Medical Systems	7,400	59.10 million	56.91 million	Optionable

MMSI, ADUS, HQY, and MEDP Headlines

Recent News About These Companies

Merit Medical is getting a new CEO

5 hours ago | massdevice.com

Merit Medical Names Medtronic Veteran Martha Aronson As Next CEO, Projects Strong Outlook

5 hours ago | benzinga.com

5MMSI : What 14 Analyst Ratings Have To Say About Merit Medical Systems

5 hours ago | benzinga.com

Needham & Company LLC Reiterates Buy Rating for Merit Medical Systems (NASDAQ:MMSI)

July 8 at 8:20 AM | marketbeat.com

Strategic Leadership Transition and Strong Financial Performance Justify Buy Rating for Merit Medical Systems

July 8 at 7:11 AM | tipranks.com

Hold Rating Maintained for Merit Medical Systems Amid Leadership Change and Cautious Market Outlook

July 8 at 5:40 AM | tipranks.com

Buy Rating for Merit Medical Systems Driven by New CEO Appointment and Strong Revenue Guidance

July 8 at 4:50 AM | tipranks.com

Principal Financial Group Inc. Has $33.82 Million Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)

July 8 at 4:13 AM | marketbeat.com

Penguin Solutions, Merit Medical Systems And 3 Stocks To Watch Heading Into Tuesday

July 8 at 2:55 AM | benzinga.com

Merit Medical Names Martha Aronson as New President and Chief Executive Officer

July 7 at 4:20 PM | globenewswire.com

Analysts Set Merit Medical Systems, Inc. (NASDAQ:MMSI) PT at $109.11

July 7 at 2:33 AM | americanbankingnews.com

Impax Asset Management Group plc Lowers Stock Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI)

July 6 at 6:15 AM | marketbeat.com

Allspring Global Investments Holdings LLC Increases Stock Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)

July 5 at 4:09 AM | marketbeat.com

Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Consensus Recommendation of "Moderate Buy" by Brokerages

July 4, 2025 | marketbeat.com

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

July 3, 2025 | gurufocus.com

Merit Medical Systems Inc (MMSI) Announces Upcoming Financial Results Release and Investor Call ...

July 3, 2025 | gurufocus.com

Merit Medical Systems, Inc. to Release Q2 2025 Financial Results and Host Investor Conference Call on July 30

July 3, 2025 | quiverquant.comQ

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025 | MMSI Stock News

July 3, 2025 | gurufocus.com

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

July 3, 2025 | globenewswire.com

XRAY or MMSI: Which Is the Better Value Stock Right Now?

July 2, 2025 | zacks.com

34,130 Shares in Merit Medical Systems, Inc. (NASDAQ:MMSI) Bought by Lisanti Capital Growth LLC

June 29, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MMSI, ADUS, HQY, and MEDP Company Descriptions

Addus HomeCare NASDAQ:ADUS

$112.07 +1.45 (+1.31%)

Closing price 04:00 PM Eastern

Extended Trading

$112.08 +0.02 (+0.01%)

As of 06:13 PM Eastern

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

HealthEquity NASDAQ:HQY

$103.12 +1.29 (+1.27%)

Closing price 04:00 PM Eastern

Extended Trading

$103.40 +0.28 (+0.28%)

As of 06:03 PM Eastern

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Medpace NASDAQ:MEDP

$322.50 +3.60 (+1.13%)

Closing price 04:00 PM Eastern

Extended Trading

$316.64 -5.86 (-1.82%)

As of 06:09 PM Eastern

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Merit Medical Systems NASDAQ:MMSI

$95.34 +4.22 (+4.63%)

Closing price 04:00 PM Eastern

Extended Trading

$95.35 +0.01 (+0.01%)

As of 06:14 PM Eastern

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time